Moderna Shares Fall 17.6% After Leak of Its Melanoma Vaccine Data

Moderna shares closed down 17.6% on Thursday after data from the trial of its melanoma vaccine leaked, according to Yahoo Finance. ABC describes the results as better than the researchers had hoped, and points to a study that found a 42% reduction, without specifying the metric the text refers to.

AI-written summary of 2 sources; every verified point is backed by a verbatim quote. How Iyan works

• Moderna's stock closed at $202.63 after its decline on Thursday.

  «Moderna (MRNA:NASDAQ) stock sank 17.6% on Thursday to close at $202.63»

  Yahoo Finance
• ABC notes that the study found a 42% reduction.

  «is detailed in a study that found a 42 per cent reduction in»

  ABC (Australian Broadcasting Corporation)
• The researchers describe the vaccine as the first cancer vaccine in the world to achieve these results.

  «Researchers say a world-first cancer vaccine is delivering results even better than they had hoped for.»

  ABC (Australian Broadcasting Corporation)

Iyan — See it for yourself. What changed in your world today, why it matters, and how we know.
How it works • Privacy • Terms